Overview
Kristian Stensland is a Urologist in Muskegon, Michigan. Dr. Stensland is rated as an Experienced provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Lichen Sclerosus, Prostate Cancer, Urethral Stricture, Cystectomy, and Prostatectomy. Dr. Stensland is currently accepting new patients.
His clinical research consists of co-authoring 94 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- HMO
- HMO
- POS
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
Locations
1500 E Sherman Blvd, Muskegon, MI 49444
19900 Haggerty Rd, Suite 111, Livonia, MI 48152
1500 E Medical Ctr Dr, Ann Arbor, MI 48109
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Urologic Consultants PC - Michigan Street
John Anema is a Urologist in Grand Rapids, Michigan. Dr. Anema has been practicing medicine for over 38 years and is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Renal Cell Carcinoma (RCC), Nephrectomy, and Reconstructive Urology Surgery. Dr. Anema is currently accepting new patients.
Corewell Health Urology - Wealthy
Christopher Brede is an Oncologist and a Urologist in Grand Rapids, Michigan. Dr. Brede has been practicing medicine for over 17 years and is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Renal Cell Carcinoma (RCC), Nephrectomy, and Reconstructive Urology Surgery. Dr. Brede is currently accepting new patients.
Center For Physical Rehabilitation And Therapy Lp
Thomas Maatman is a Urologist in Grand Rapids, Michigan. Dr. Maatman is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Enlarged Prostate (BPH), Vasectomy, and Nephrectomy. Dr. Maatman is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Bladder CancerDr. Stensland isAdvanced. Learn about Bladder Cancer.
- CystectomyDr. Stensland isAdvanced. Learn about Cystectomy.
- Lichen SclerosusDr. Stensland isAdvanced. Learn about Lichen Sclerosus.
- Prostate CancerDr. Stensland isAdvanced. Learn about Prostate Cancer.
- ProstatectomyDr. Stensland isAdvanced. Learn about Prostatectomy.
- Urethral StrictureDr. Stensland isAdvanced. Learn about Urethral Stricture.
- Experienced
- Chromophobe Renal Cell CarcinomaDr. Stensland isExperienced. Learn about Chromophobe Renal Cell Carcinoma.
- Clear Cell SarcomaDr. Stensland isExperienced. Learn about Clear Cell Sarcoma.
- Enlarged Prostate (BPH)Dr. Stensland isExperienced. Learn about Enlarged Prostate (BPH).
- Familial Prostate CancerDr. Stensland isExperienced. Learn about Familial Prostate Cancer.
- Familial Wilms Tumor 2Dr. Stensland isExperienced. Learn about Familial Wilms Tumor 2.
- Muscle Invasive Bladder CancerDr. Stensland isExperienced. Learn about Muscle Invasive Bladder Cancer.